RemedyMD announces new ComprehensiveBMT to solve key HSCT research challenges

RemedyMD has identified the need within the HSCT community to build software that can aggregate, link, harmonize, and analyze data from patients and donors and then report data as necessary to the CIBMTR. Today, the company has announced its new product, which solves these challenges and many others, calling it ComprehensiveBMT. This new product solves key challenges of hematopoietic stem cell transplant research such as

“ComprehensiveBMT—Redefining HSCT Data Aggregation, Analysis, and Reporting”

• Electronically reporting essential and comprehensive data to the NMDP/CIBMTR
• Linking together HSCT data contained in myriad spreadsheets or databases
• 'Harmonizing' that data with an AGNIS-approved ontology so it's consistent and research-ready
• Setting up and managing studies and experiments as well as patient/donor information, and
• Having robust tools and applications to mine, query, and report on that data

ComprehensiveBMT includes a complete HSCT Registry linking together data from many disparate sources such as EHR clinical data, research databases and spreadsheets, gene arrays, imaging data, patient and donor self-reported data, and many others. By linking together all of these data sources and then 'normalizing' that data HSCT researchers gain a 360° view of every patient or subject to recognize patterns or identify trends that were not visible without a comprehensive registry and sophisticated data analysis tools.

Matthew Gress, ComprehensiveBMT product manager, adds, "RemedyMD worked closely with the CIBMTR when building the forms included with the product, and we're very happy with the end result. Users get the benefit of submitting forms electronically, with a built-in ontology that works with AGNIS, plus all of the Mosaic™ Meta-Registry data infrastructure and tools for collecting and normalizing data, mining that data, and even managing studies and experiments."

"Building ComprehensiveBMT was an excellent way to affirm the robustness of our tool set. We were able to build out this BMT Registry including all the essential forms and all the approved comprehensive level forms is less than three weeks," said Jim Hyde, President and COO of RemedyMD. "We are committed to using our technology platform to stay ahead of the new comprehensive forms as they are released."